Dentsply Sirona Inc
$ 12.55
0.08%
23 Feb - close price
- Market Cap 2,504,377,000 USD
- Current Price $ 12.55
- High / Low $ 12.68 / 12.17
- Stock P/E N/A
- Book Value 7.41
- EPS -4.40
- Next Earning Report 2026-02-26
- Dividend Per Share $0.64
- Dividend Yield 5.1 %
- Next Dividend Date -
- ROA 0.03 %
- ROE -0.44 %
- 52 Week High 18.27
- 52 Week Low 9.71
About
Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.
Analyst Target Price
$13.23
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-04-30 | 2025-02-26 | 2024-11-07 | 2024-07-31 | 2024-05-02 | 2024-02-29 | 2023-11-02 | 2023-08-02 | 2023-05-03 | 2023-02-28 |
| Reported EPS | 0.5 | -0.23 | 0.43 | 0.26 | 0.5 | 0.49 | 0.42 | 0.44 | 0.49 | 0.51 | 0.39 | 0.46 |
| Estimated EPS | 0.45 | 0.5 | 0.3002 | 0.434 | 0.47 | 0.5 | 0.42 | 0.43 | 0.48 | 0.43 | 0.34 | 0.32 |
| Surprise | 0.05 | -0.73 | 0.1298 | -0.174 | 0.03 | -0.01 | 0 | 0.01 | 0.01 | 0.08 | 0.05 | 0.14 |
| Surprise Percentage | 11.1111% | -146% | 43.2378% | -40.0922% | 6.383% | -2% | 0% | 2.3256% | 2.0833% | 18.6047% | 14.7059% | 43.75% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.28 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-09 | 2025-10-10 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 | 2024-01-12 | 2023-10-13 |
| Amount | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.14 | $0.14 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: XRAY
2026-02-21 09:52:59
Brickwood Asset Management LLP significantly increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5,515.8% in Q3, acquiring 1,496,935 shares and now holding 1,524,074 shares worth $19.34 million. This makes DENTSPLY SIRONA its 5th largest holding, representing 14.7% of its portfolio. Other institutional investors also added to their positions, indicating strong institutional interest despite mixed analyst ratings and an upcoming earnings report that could create volatility.
2026-02-20 09:27:30
Dentsply Sirona is introducing two new webinars on its Dentsply Sirona Academy Campus focusing on implant dentistry. The first webinar, "Prosthetic dentistry in the digital era," will explore the impact of AI and cloud-based platforms on prosthetic workflows, presented by Prof. Stefan Vandeweghe. The second, "Managing implant restoration complications," will guide clinicians on identifying and addressing common issues, led by Dr. Varisha Parikh.
2026-02-19 15:58:01
DENTSPLY SIRONA (NASDAQ:XRAY) shares gapped up after Bank of America upgraded the stock from a "neutral" to a "buy" rating, raising its price target from $13 to $17. The stock opened at $13.12, up from its previous close of $12.49. Despite the upgrade, analyst coverage remains mixed with an average "Hold" rating and a target price of $14.46 across various research firms.
2026-02-19 14:58:01
Bank of America has upgraded Dentsply Sirona's (XRAY) stock from Neutral to Buy, increasing its price target to $17 from $13. The upgrade is attributed to a compelling risk-reward opportunity for the dental product manufacturer. Following this news, shares of Dentsply Sirona traded higher on Thursday.
2026-02-19 13:58:01
Bank of America has upgraded DENTSPLY SIRONA (NASDAQ:XRAY) from "neutral" to "buy" and increased its price target to $17, suggesting a 36.11% upside. Other analysts have varying opinions, leading to a consensus "Hold" rating with an average price target of $14.46. Insider sales and institutional ownership figures are also detailed in the report.
2026-02-19 12:58:01
BofA Securities upgraded Dentsply Sirona (NASDAQ:XRAY) stock from Neutral to Buy, raising its price target to $17 from $13 due to perceived undervaluation and a positive risk/reward profile. The upgrade is based on BofA's expectation that the dental equipment maker's valuation gap with peers will narrow in 2026, driven by new management's progress in distributor relationships and potential multiple expansion. The firm also noted recent significant developments including renewed distribution agreements and leadership appointments.
